Scribd
Upload
53 views2 pages

Refrensi

1. The document lists 15 references on the topic of cutaneous drug reactions. The references are journal articles, book chapters, and online medical references published between 2000-2013. 2. Many of the references discuss specific drug reactions like drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome, toxic epidermal necrolysis, and linear immunoglobulin A bullous dermatosis. 3. Assessment methods for cutaneous adverse drug reactions like patch testing and causality assessment are also covered in some of the references.

Uploaded by

John Thunder
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
53 views2 pages

Refrensi

1. The document lists 15 references on the topic of cutaneous drug reactions. The references are journal articles, book chapters, and online medical references published between 2000-2013. 2. Many of the references discuss specific drug reactions like drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome, toxic epidermal necrolysis, and linear immunoglobulin A bullous dermatosis. 3. Assessment methods for cutaneous adverse drug reactions like patch testing and causality assessment are also covered in some of the references.

Uploaded by

John Thunder
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

DAFTAR PUSTAKA

1. Svensson CK, Cowen EW, Gaspari AA. Cutaneous Drug Reactions. Pharmacol
Rev [Internet]. 2000 [disitasi 2017 Nov 6]; 53(3); [357-379]. Diambil dari:
http://pharmrev.aspetjournals.org/content/pharmrev/53/3/357.full.pdf
2. Babu KS dan Belgi G. Management of Cutaneous Drug Reactions. Curr Asth
and Allerg Rep [Internet]. 2002 [disitasi 2017 Nov 7]; 2; [26-33]. Diambil dari:
https://link.springer.com/article/10.1007/s11882-002-0034-x
3. Goldsmith LA et.al., Fitzpatrick’s Dermatology in General Medicine. 8th ed.
New York: McGraw Hill; 2012.
4. Mahajan VK dan Handa S. Patch Testing in Cutaneous Adverse Drug
Reactions: Methodology, Interpretation and Clinical Relevance. Indian J
Dermatol Venereol Leprol [Internet]. 2013 Nov-Des [disitasi 2017 Nov 7];
79(6); [836-841]. Diambil dari: http://www.ijdvl.com/article.asp?issn=0378-
6323;year=2013;volume=79;issue=6;spage=836;epage=841;aulast=Mahajan
5. Son YM, Lee JR, Roh JY. Causality Assessment of Cutaneous Adverse Drug
Reactions. Ann Dermatol [Internet]. 2011 April 26 [disitasi 2017 Nov 7]; 23 (4);
[432-438]. Diambil dari:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229935/
6. Ramdial PK dan Naidoo DK. Drug-induced Cutaneous Pathology. J Clin Pathol
[Internet]. 2009 Jan 20 [disitasi 2017 Nov 8]; 62; [493-504]. Diambil dari:
https://www.ncbi.nlm.nih.gov/pubmed/19155238
7. Hiransuthikul A et.al., Drug Induced Hypersensitivity Syndrome/ Drug Reaction
with Eosinophilia and Systemic Symptoms (DIHS/DRESS): 11 years
retrospective study in Thailand. Allergology Int [Internet]. 2016 Mar 26 [disitasi
2017 Nov 9]; 2016; [1-7]. Diambil dari: http://www.mdpi.com/1422-
0067/18/6/1243/pdf-vor
8. Shahnaz A, Ramezani K, Chavoshzadeh Z, Mansouri M. Drug Rash with
Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two
Rare Cases. J Compr Ped [Internet]. 2013 Aug 11 [disitasi 2017 Nov 9]; 4(4);
[200-202].Diambil dari: http://cdn.neoscriber.org/cdn/dl/5d7beb26-509f-11e7-
873f-2b08a548acfd
9. Kellett S dan Cock C. A Case of Drug Reaction with Eosinophilia and Systemic
Symptoms. Case Rep in Med [Internet]. 2012 Jul 16 [disitasi 2017 Nov 9]; 2012;
[1-4]. Diambil dari: https://www.hindawi.com/journals/crim/2012/705190/
10. Grattan C. The Urticarias: Pathophysiology and Management. Clin Med
[Internet]. 2012 [disitasi 2017 Nov 6]; 12(2); [164-167]. Diambil dari:
http://www.clinmed.rcpjournal.org/content/12/2/164.full
11. Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous
dermatosis. Clin Dermatol. 2012;30:38–50. 4
12. 5. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck
JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome
and toxic epidermal necrolysis: assessment of medication risks with emphasis
on recently marketed drugs. The EuroSCAR-study. J Invest
Dermatol. 2008;128:35–44. doi: 10.1038/sj.jid.5701033. 5
13. 6. Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced
skin necrosis. J Am Acad Dermatol. 2009;61:325–332. 6
14. Samel Andrew, Drug Eruption. UpToDate. 2013. Diakses 9 November 2017.
http://iranuptodate.ir/contents/mobipreview.htm?40/17/41241#H20
15. Romano A, Viola M, Gaeta F, Rumi G, Magioletti M. Patch Testing in Non
Immediate Drug Eruptions. Allerg Asth and Clin Immun [Internet]. 2008
[disitasi 2017 Nov 10]; 4(2); [ 66-74]. Diambil dari:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868884/

You might also like